Africans and African Americans are among the most underrepresented populations in genetic health research, yet they face some of the most daunting health outcomes.It’s a bitter irony of the current...

23andMe scientists have studied three years of survey data to find out more about who makes and keep their New Year's resolutions.

In the largest genetic study to date on Polycystic ovary syndrome, a leading cause of female infertility, an international team of scientists using data from more than 100,000 women including data from consenting 23andMe customers, found new genetic associations for the condition and further evidence of its associations with metabolic disorders, menopause, and depression.

To learn more about the genetics of ice cream consumption and taste preference, 23andMe researchers found genetic associations near genes in the olfactory receptor family as well as surprising associations with genes that influence preferences for milk chocolate or dark chocolate.

23andMe's Global Genetics Project aims to enroll more than 10,000 people over two years from communities in Africa, Asia, Oceania, and the Americas, who are not currently well represented in genetic research. The data will help diversity 23andMe’s database and thus improve results for our customers; it will also boost genomic studies in underrepresented populations worldwide.

Research at 23andMe includes both traditional rigorous scientific inquiry and publishing in peer-reviewed publications, but also occasionally a lighter approach for sharing insights from customers who have consented to participate in research.

This is the third and final set of videos from 23andMe’s new series, The DNA Download, and it offers a nice way to explain another core focus of the company,...

23andMe scientists present findings on using a new statistical model that combines data like sun exposure along with genetic data, to better predict skin cancer risk.

To ensure that our customers can easily see how their contributions are making a difference, 23andMe created a new Research Overview page.

23andMe announces the launch of a collaboration with GlaxoSmithKline (GSK) to accelerate our ability to make meaningful discoveries in therapeutics to treat disease.